A £1.7million grant has been awarded to The University of Glasgow to create the world’s largest Immune Mediated Inflammatory Disease (IMID) Biobank. IMID are common medical conditions that cause pain, distress, loss of function and early death. The biobank will be used to create a ‘superhighway’ of information that can be analysed in order to apply a precision medicine approach to these health conditions. To...
A study in to breeding low emission cattle has been awarded the widely respected, PLOS Genetic prize. Working in collaboration, Scotland’s Rural College, The Roslin Institute and The University of Aberdeen studied the link between the genetic background of an animal, it’s diet and the composition of its microbial community. To read the full article, click here.
Leaders in gene control, Synpromics have announced their new research partnership with Solid Biosciences LLC. The partnership will focus on research around developing treatment options for Duchenne muscular dystrophy (DMD). DMD is a muscle-wasting disease that is progressive, irreversible and ultimately fatal. Currently there is no cure and unsatisfactory treatments for patients. The research aims to advance Solid Biosciences AAV muscle-directed gene therapy research programme....
Developments in a technique known as ‘nanokicking’ allows scientist to grow 3D samples of mineralised bone in a lab. Currently surgeons can only harvest small amounts of living bone from the patient to use as a graft. The lab-grown bone can be implanted to the patient to repair or replace damaged sections of bone. To read the full article, click here.
Universities of Dundee and Cambridge have developed a new diagnostic test for the African Sleeping Sickness disease. The disease causes thousands of deaths each year and is caused through parasites transmitted by tsetse flies in sub-Saharan Africa. The newly developed SD Bioline Hat 2.0 test requires no specialist equipment and costs just US $0.50 per test. To read the full article, click here.
NHS Research Scotland’s world class reputation will be promoted in the USA whilst meeting research and development leads from US based life science companies. Along with representatives from England, Wales and Northern Ireland health research bodies, they will promote the UK as a global hub for medical innovation and research. To read the full article, click here.